SCHEMBL28891099

SCHEMBL28891099

COC(=O)NC1(COc2ccc(F)c3c2CCC(=O)N3Cc2ccc(OC)cc2)CCN(c2ncc(Cl)cc2Cl)CC1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ P2RY12 Q9H244 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ POLB P06746 2/20 0.35
▸ CXCR3 P49682 2/20 0.34
▸ KCNN4 O15554 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ GRM2 Q14416 2/20 0.32
▸ CACNA1H O95180 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17542816 0.94 P2RY12 (0.37) C5AR1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL28422841 0.89 P2RY12 (0.38) C5AR1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL17543000 0.89 SMN1; SMN2 (0.38) C5AR1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL17542922 0.89 SMN1; SMN2 (0.37) C5AR1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL17543308 0.87 SMN1; SMN2 (0.36) C5AR1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL17543861 0.87 KCNN4 (0.36) C5AR1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL17543550 0.87 SMN1; SMN2 (0.36) C5AR1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL17543548 0.86 P2RY12 (0.38) C5AR1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL17543473 0.86 KCNN4 (0.35) C5AR1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL17543452 0.86 P2RY12 (0.40) MAPTSMN1; SMN2CYP2C9CYP2C19P2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106795117-B Heterobicyclic compounds and their use for the treatment of tuberculosis 大塚制药株式会社 2020-06-26 — — CN disclosed
Send feedback